Measurements of target volumes and organs at risk using DW‑MRI in patients with central lung cancer accompanied with atelectasis

Mol Clin Oncol. 2023 Apr 13;18(6):45. doi: 10.3892/mco.2023.2641. eCollection 2023 Jun.

Abstract

Accurate imaging-based tumor delineation is crucial for guiding the radiotherapy treatments of various solid tumors. Currently, several imaging procedures, including diffusion-weighted magnetic resonance imaging (DW-MRI), intensified computed tomography and positron emission tomography are routinely used for targeted tumor delineation. However, the performance of these imaging procedures has not yet been comprehensively evaluated. In order to address this matter, the present study was conducted in an aim to assess the use of DW-MRI in guiding radiotherapy treatments, by comparing its performance to that of other imaging procedures. Specifically, the exposure dosages to organs at risk, including the lungs, heart and spinal mencord, were evaluated using various radiotherapy regimes. The findings of the present study demonstrated that DW-MRI is a non-invasive and cost-effective imaging procedure that can be used to reduce lung exposure doses, minimizing the risk of radiation pneumonitis. The data further demonstrate the immense potential of the DW-MRI procedure in the precision radiotherapy of lung cancers.

Keywords: atelectasis; central lung cancer; diffusion-weighted magnetic resonance imaging; organs at risk; radiotherapy.

Grants and funding

Funding: The present study was supported by the National Natural Science Foundation of China (NSFC; grant nos. 81272699, 81301936 and 81472811), the Shandong Science and Technology Development Project (grant no. 2014GGC03038) and the International Cooperation Project of Science and Technology Department (grant no. 2012DFA31560).